Altogen Labs is a preclinical research organization specializing in the testing and evaluation of novel pharmacological and biological treatments, including novel anticancer therapies, medical compounds, vaccines, cosmetics, and a wide array of natural products and extracts. With a dedicated team of scientists, Altogen Labs provides a comprehensive suite of laboratory services, utilizing the latest technologies […] The post Preclinical Research with Advanced Oncology Models and Immunooncolo...| Transfection Reagents | Cell Lines, In Vivo | Altogen Biosystems
Altogen Labs is a GLP-compliant biotech laboratory that specializes in oncology research studies and provides preclinical testing of new medicines that often require a sequence of experiments utilizing various scientific methods to demonstrate novel compound anti-cancer efficacy, safety, and mechanism of action. Breast cancer is the second leading cancer that causes death in women globally, […] The post Validated Breast Cancer Xenograft Models appeared first on Transfection Reagents | Cell ...| Transfection Reagents | Cell Lines, In Vivo | Altogen Biosystems
LAS VEGAS, NEVADA – July 19, 2021 – Altogen Biosystems, leading manufacturer of in vivo transfection products, announced today that Altogen’s nanoparticle-based in vivoTransfection reagent (catalog #5031) was demonstrated to be effective for glioblastoma-targeted co-delivery of plasmid DNA (3.7 kb) and chemically modified siRNA. This transfection reagent was used in over 30 research publications, demonstrating highly […] The post In Vivo Nanoparticle Transfection Reagent is Effective...| Transfection Reagents | Cell Lines, In Vivo | Altogen Biosystems
July 27, 2021 – Altogen Biosystems® is a biotechnology manufacturing company that specializes in the development and testing of optimized cell transfection reagents and kits for both in vitro and in vivo delivery. In 2018 Altogen Biosystems launched the AltoFect transfection reagent formulated for difficult-to-transfect cells (like B-cells, T-cells), and primary cell cultures that are […] The post Crossing Blood-Brain Barrier: Delivery of Biomolecules into Glioblastoma Enabled by Altogen...| Transfection Reagents | Cell Lines, In Vivo | Altogen Biosystems